HYPERTENSION IN DIABETES STUDY (HDS) .1. PREVALENCE OF HYPERTENSION IN NEWLY PRESENTING TYPE-2 DIABETIC-PATIENTS AND THE ASSOCIATION WITH RISK-FACTORS FOR CARDIOVASCULAR AND DIABET... Tekijä Turner, R, Holman, R, Matthews, D, Bassett, P, Coster, R, Stratton, I, Cull, C, Peto, R, Frighi, V, Kennedy, I, Manley, S, Bown, E, Eeley, E, Ross, I, Matthews, D, Dornan, T, Wright, A, Neil, H, Kohner, E, Aldington, S, Keen, N, Rose, C, Fletcher, A, Battersby, C, Yudkin, J

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. Tekijä Turner, R, Holman, R, Matthews, D, Bassett, P, Coster, R, Stratton, I, Cull, C, Peto, R, Frighi, V, Kennedy, I, Manley, S, Bown, E, Eeley, E, Ross, I, Matthews, D, Dornan, T, Wright, A, Neil, H, Kohner, E, Aldington, S, Keen, N, Rose, C, Fletcher, A, Battersby, C, Yudkin, J

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. Tekijä Stearne, MR, Palmer, S, Hammersley, MS, Franklin, S, Spivey, R, Levy, J, Tidy, C, Bell, N, Steemson, J, Barrow, B, Coster, R, Waring, K, Nolan, L, Truscott, E, Walravens, N, Cook, B, Lampard, H, Merle, C, Parker, P, McVittie, J, Draisey, I, Murchison, L, Brunt, A, Williams, M, Pearson, D

Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 Tekijä Stearne, MR, Palmer, S, Hammersley, MS, Franklin, S, Spivey, R, Levy, J, Tidy, C, Bell, N, Steemson, J, Barrow, B, Coster, R, Waring, K, Nolan, L, Truscott, E, Walravens, N, Cook, L, Lampard, H, Merle, C, Parker, P, McVittie, J, Draisey, I, Murchison, L, Brunt, A, Williams, M, Pearson, D

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Tekijä Stearne, MR, Palmer, S, Hammersley, MS, Franklin, S, Spivey, R, Levy, J, Tidy, C, Bell, N, Steemson, J, Barrow, B, Coster, R, Waring, K, Nolan, J, Truscott, E, Walravens, N, Cook, L, Lampard, H, Merle, C, Parker, P, McVittie, J, Draisey, I, Murchison, L, Brunt, A, Williams, M, Pearson, D

Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective? Tekijä Mastantuono, E, Repp, B, Alston, CL, Schiff, M, Haack, TB, Rotig, A, Ardissone, A, Lombes, A, Catarino, CB, Diodato, D, Schottmann, G, Poulton, J, Burlina, A, Jonckheere, A, Munnich, A, Ghezzi, D, Rokicki, D, Wellesley, D, Martinelli, D, Lamantea, E, Ostergaard, E, Pronicka, E, Pierre, G, Smeets, HJ, Scurr, I, De Coo, IF, Moroni, I, Smet, J, Mayr, JA, De Meirleir, L, Schuelke, M, Zeviani, M, McFarland, R, Seneca, S, Klopstock, T, Meitinger, T, Strom, TM, Herberg, U, Sperl, W, Nassogne, M, Ling, H, Fang, F, Freisinger, P, Van Coster, R, Taylor, RW, Haberle, J, Vockley, J, Prokisch, H, Wortmann, S